Compare, Analyse GSK Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
GSK PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,595381-   
Low Rs1,253275-   
Sales per share (Unadj.) Rs184.7113.2-  
Earnings per share (Unadj.) Rs26.3-28.5-  
Cash flow per share (Unadj.) Rs29.2-23.6-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.388.9-  
Shares outstanding (eoy) m169.40168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.12.9 453.7%   
Avg P/E ratio x92.2-11.5 -802.9%  
P/CF ratio (eoy) x83.1-13.9 -599.9%  
Price / Book Value ratio x19.23.7 520.6%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,62655,292 742.6%   
No. of employees `0005.04.3 115.5%   
Total wages/salary Rs m5,3723,470 154.8%   
Avg. sales/employee Rs Th6,306.74,451.4 141.7%   
Avg. wages/employee Rs Th1,083.1808.4 134.0%   
Avg. net profit/employee Rs Th898.0-1,121.7 -80.1%   
INCOME DATA
Net Sales Rs m31,28119,110 163.7%  
Other income Rs m1,023134 764.6%   
Total revenues Rs m32,30419,244 167.9%   
Gross profit Rs m6,009-3,312 -181.4%  
Depreciation Rs m486825 58.9%   
Interest Rs m6518 1.2%   
Profit before tax Rs m6,540-4,520 -144.7%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,373282 840.1%   
Profit after tax Rs m4,454-4,815 -92.5%  
Gross profit margin %19.2-17.3 -110.8%  
Effective tax rate %36.3-6.2 -580.7%   
Net profit margin %14.2-25.2 -56.5%  
BALANCE SHEET DATA
Current assets Rs m20,06113,997 143.3%   
Current liabilities Rs m14,5437,875 184.7%   
Net working cap to sales %17.632.0 55.1%  
Current ratio x1.41.8 77.6%  
Inventory Days Days57111 51.2%  
Debtors Days Days14124 11.3%  
Net fixed assets Rs m14,3438,159 175.8%   
Share capital Rs m1,69489 1,909.3%   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,39814,999 142.7%   
Long term debt Rs m25,271 0.0%   
Total assets Rs m39,11328,335 138.0%  
Interest coverage x1,091.0-7.7 -14,109.7%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.7 118.6%   
Return on assets %11.4-15.2 -75.2%  
Return on equity %20.8-32.1 -64.8%  
Return on capital %31.9-19.8 -161.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,9941,631 244.8%  
From Investments Rs m-1,433-501 286.2%  
From Financial Activity Rs m-3,5844,784 -74.9%  
Net Cashflow Rs m-1,0235,914 -17.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.25 Rs / ZAR

Compare GSK PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: AUROBINDO PHARMA  VENUS REMEDIES  DR. REDDYS LAB  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views On News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

GSK PHARMA SHARE PRICE


May 12, 2021 03:36 PM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS